Nassau Street Ventures
670 N. Commercial Street Suite 403, Manchester, NH, 03101, United States
Overview
Nassau Street Ventures is a venture capital fund for alumni of Princeton that invests in companies with a Princeton connection.
- Total investments
- 7
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 1
Sector focus
- Financial Services
Investment portfolio
- Fetch
Participated · Equity · Mar 2022
Fetch’s core product is a marketplace and app that lets users find nearby trucks or vans, reserve them, and unlock the vehicle from their phone using Fetch’s hardware. The marketplace includes vehicles owned by Fetch as well as third-party fleet operators and individuals who install Fetch’s hardware to enable phone unlocking. Renters must carry their own insurance; Fetch provides secondary insurance to augment those policies. The company says it has “hundreds of trucks live on the marketplace,” with about half currently in the Atlanta area, and that it has achieved profitability on a per-rental basis. Fetch has partnered with Home Depot to power the retailer’s rental process in select areas and currently charges variable pricing (for example, a 6' pickup in Atlanta listed at $19/hour or $70/day with 50 miles included). The team is 12 people now and plans to double headcount in the next three months while expanding into roughly 12 more cities by the end of the year.
- Centivo
Participated · Equity · Sep 2021
Centivo builds employer-focused, primary care-centered health plans that combine an in-house virtual primary care practice (Centivo Care), direct contracts with accountable care organizations (ACOs) in 18 major markets, and a tech-enabled member engagement and plan administration platform. The company says its model can lower total cost of care by 30% or more, typically saves employers 15% or more, and increased utilization of primary and specialty care. In 2023 Centivo’s health plans achieved a 71% reduction in member out-of-pocket costs compared to the plans they replaced, and the company says its approach reduces annual employee out-of-pocket costs by nearly $1,200. Following Centivo’s acquisition of virtual-first medical provider Eden Health in May, the company expanded its PCMH-certified virtual primary care capabilities and integrated behavioral health into its platform. Centivo serves Americans in all 50 states across a diverse set of industries and plans to use recent capital to enhance and scale its product and technology and forge new strategic partnerships with health systems. Its stated mission is to bring affordable, high-quality healthcare to working families by curbing inefficiency and waste in employer-sponsored plans. Centivo offers health plans for self-insured employers anchored around relationships with accountable care providers and a primary-care-centered clinical model. Its plan designs include free adult and pediatric primary care for all visits, no deductibles, predictable copays for non-primary care, and integrated virtual primary care. Centivo says employers typically save 15–30% annually versus traditional insurance and that members’ medical and pharmacy out-of-pocket costs average under $350 per person per year. The company reports primary care utilization has increased by more than 30% while quality and member satisfaction have strengthened. Centivo serves employers ranging from 51 employees to Fortune 500 companies and has a market presence in 13 states. The company launched in 2019 and is pursuing rapid growth and expansion amid increased employer demand. Centivo is a Buffalo, NY-based health plan company led by CEO Ashok Subramanian. Its core product is a health plan anchored around providers of value-based care for self-funded employers. The company serves employer clients ranging in size from 100 employees to Fortune 500 companies. It recently launched a fully integrated virtual primary care-centered health plan in Florida. Centivo plans to use new funding for growth, expansion and development of products and services, including its virtual primary care-centered plan. By the end of 2022 the company’s health plan will be available in half of the top 20 metropolitan areas in the country, and it has a new strategic distribution arrangement with the Business Health Care Group in eastern Wisconsin. Centivo provides a benefits solution built for self-funded employers, offering affordable and predictable costs, a technology-driven member experience, and a range of benefit options including traditional and proprietary networks. The company develops high-value networks in partnership with local healthcare providers and uses data analytics to refine networks and direct members to appropriate providers. Members receive a primary care–centered model with expanded access and fully integrated virtual care. Provider partners include health systems such as Mount Sinai Health System, Orlando Health, Scripps Health, and UCLA Health, as well as independent practices. Centivo’s solution is available to mid-sized and large employers in New York, New Jersey, Connecticut, Southern California, Florida, and North Carolina, with plans to expand to additional markets in 2021. The company is led by CEO and co-founder Ashok Subramanian and has offices in Stamford, CT; Buffalo, NY; and New York, NY. Centivo is a New York City–based, new type of self-funded health plan built specifically for employers and their employees and families. Led by CEO and co-founder Ashok Subramanian, the company serves as a health plan or third-party administrator and partners closely with local health plans and TPAs to enhance offerings. Its model centers on an innovative primary care–centered network focused on outcomes, a dynamic benefit design that rewards members for high-value care and adherence, and a digital technology platform and concierge support to improve care and experience. Centivo is launching its product for the 2019 plan year, focusing on employers with employees in New York, New Jersey, Connecticut, and select other markets. The company plans to deploy capital to build technology and infrastructure, develop local partnerships, and support market launch.
- Conversa Health
Participated · Series B · Jan 2021
Conversa Health provides an enterprise virtual care and communication platform that links providers’ EHRs and patient data to interactive digital care pathways and a clinical analytics engine to automate care management 24×7. Its platform and library of digital pathways are used by providers to manage patients across populations rather than one-off point solutions, improving pre- and post-visit care-plan adherence. During the COVID-19 pandemic the company’s customer count grew fourfold and its financial metrics increased sixfold as larger customers expanded use of the platform. Conversa is expanding its product to support vaccination programs for consumer education and post-vaccination monitoring. To capitalize on recent momentum the company plans to hire more engineers and scale the platform. Company leadership believes remote and automated care will remain in demand after the pandemic and anticipates significant growth in virtual care delivery. Conversa Health offers an automated, chat-based virtual care and communication platform that triages patients, gathers patient data, and integrates with connected devices. The company positions its platform as the digital front door for health systems, aiming to scale personalized engagement and care. Conversa has launched Employee HealthCheck to screen workers before they return to work and has additional programs to screen for mental health concerns. The platform is being used by providers to check patients and loved ones before facility visits and to manage COVID-related workflows. Northwell Health has used Conversa to scale communications and care for thousands of COVID-19 patients with programs focused on lab results, quarantine and antibody tests. The company characterizes itself as, in many ways, a data company. Conversa is a San Francisco-based healthcare conversation platform that aims to improve doctor–patient communication. Its Conversa Conversation Platform™ delivers smart, automated, patient-profile driven conversations across key health experiences including chronic condition management, post-discharge and pre- and post-surgery care, patient education, medication adherence, appointment scheduling and lifestyle coaching. The platform sources data from more than 400 biometric devices together with clinical, claims and patient-generated data to provide providers with real-time information for care adjustments and resource allocation. Conversa is being adopted by health systems such as Northwell, Ochsner Health System, Citrus Valley Health Partners and Centura Health’s Penrose St. Francis. Led by CEO and co-founder West Shell III, the company plans to use its newly raised capital to expand product capabilities, grow its clinical conversation library, enhance customer and distribution partner operations, and scale the team. Financially, Conversa secured $8M in Series A funding led by Northwell Ventures with participation from Epic Ventures, Healthgrades and existing investors. Conversa Health is a San Francisco, CA–based provider of patient relationship management services. Led by co-founder and CEO West Shell III and newly named CTO Daniel Dean, the company offers its Digital Checkup™ platform. The Digital Checkup™ automates delivery of personalized messaging based on a longitudinal patient profile dynamically derived from EHRs, biometric devices and self-reported data. Conversa aims to enhance the physician–patient relationship through continuous, collaborative, structured communications between visits. The company closed a $2.5M seed funding round and intends to use the proceeds to expand its Digital Checkup service with distribution partners in care management, population health and customer relationship management.
- Arable
Participated · Series B · Oct 2020
Arable builds an integrated solution combining connected sensors, agronomic models, and a software suite to provide weather, soil, plant-health and irrigation insights for farmers, agronomists and food companies. Its platform combines sensor data and machine learning to support on‑farm decisions, optimize water use, and benchmark sustainability and carbon outcomes. Customers have used Arable to reduce irrigation by up to 50% and pesticide use by about 15% in deployed cases cited by the company. Arable serves customers in over 40 countries and works with partners including Bayer, Netafim, The Nature Conservancy, Treasury Wine Estates and The World Food Programme. The company reports four‑time growth in annual recurring revenue each of the last two years, a 200% increase in active mobile app users over the past 12 months, and has doubled its team while adding offices in Sao Paulo and Bangalore. With the new funding Arable plans to accelerate product development, deliver new services, and expand its global footprint to advance climate resilience in agriculture. Arable provides an integrated system of hardware, agronomic modeling, and software that uses spectral and thermal sensors plus unique rain‑measurement microphones to observe crops continuously and diagnose stress. Its products fuse ground devices, forecasts, satellite data, and APIs to deliver actionable intelligence to farmers, researchers, processors, and food companies. The company reports just over 300% sales growth through Q3 2020 and has deployed thousands of devices across hundreds of thousands of farm acres, covering 37 crops in 39 countries on six continents. Arable’s calibration‑validation network includes more than 30 scientific research sites and its system collects over 36 million data points per day. The team emphasizes data quality, accuracy, and intuitive design and partners with major agriculture players such as Bayer, BASF, Corteva, and Treasury Wine Estates. With the new capital, Arable plans to accelerate global commercial growth and build the next phase of its predictive data products. The company is led by CEO Jim Ethington and Founder & Chief Scientist Adam Wolf and is based in San Francisco, CA. Arable makes solar-powered sensors (Arable Mark, formerly the Pulsepod) and the Arable Insights software platform to collect and analyze plant, light and weather data for farms. Its sensors measure more than 40 different, relevant data types, aiming to provide broader field visibility than single-focus IoT devices. The platform helps farmers automate monitoring, improve forecasting and reduce supply chain risk by surfacing onset of blooms, cluster development and crop coloring. Arable positions its data as valuable to farmers and downstream buyers — processors and grocers — for reducing distribution and procurement risk. The company says the capital raised will be used to hire scientists and engineers and to ramp up sensor production. Arable Labs builds the Pulsepod, a professional-grade, solar-powered crop and weather sensor that pairs with cloud software and developer tools. The device is ruggedly designed by Fred Bould and contains a six-band spectrometer, a 4-way net radiometer and an acoustic rain gauge. Each Pulsepod continuously monitors crop growth, rainfall, crop water demand, light and heat levels and crop color to inform harvest timing and yield forecasts. Data are sent to the cloud and accessible via Arable’s app and API for custom forecasting and analysis. Early adopters include Valley Irrigation, Yara International, Francis Ford Coppola Winery, Treasury Wine Estates, Driscoll’s and Blue Marble Microinsurance. Longer term the company says the sensors could be used beyond agriculture for urban flooding, water quality or fire management, though current focus remains on food farmers and reducing food waste.
- Appify
Participated · Series A · Jul 2020
Turbo Systems offers a universal no-code engagement platform and native mobile/web apps that let companies build business apps without existing infrastructure; its Turbo Flex feature specifically enables app-building with no prior infrastructure. The platform integrates with Salesforce, QuickBooks and Oracle and syncs with SAP, ServiceNow, Microsoft Dynamics and more, and supports public and private cloud deployments with native Android, iOS and web apps offering 100% offline mobility and sync. Turbo targets companies with large field service teams and the broader deskless workforce, positioning its product for the estimated 2.7 billion deskless workers globally. Since founding in 2017 and operating from Silicon Valley, Turbo has added functionality and customers while continuing product upgrades. The company reports ARR growth of 70% over the last quarter and has over 35 customers, including Keysight, United Service Technologies, Johnson & Johnson and Relo Solutions Group, with traction across industries such as commercial food, ATM, construction, medical devices, semiconductor and technology. Turbo plans to use additional funding to expand its team, accelerate revenue and customer growth, and continue adding functionality and integrations to its platform. Turbo Systems offers the first universal, no-code engagement platform for enterprises, allowing users to instantly create rich applications that extend ERP, CRM, and HRIS systems of record. Led by founder and CEO Hari Subramanian, the former CTO of ServiceMax, Turbo emphasizes a vendor- and system-neutral approach that complements and integrates with systems such as Salesforce and SAP. The platform enables truly no-code creation, deployment, and adoption of purpose-built enterprise applications without developer expertise, supporting use cases like work orders, checklists, inspections, and inventory. It supports offline and mobile workflows and is designed to scale and evolve with enterprises, enabling mass customization and next-generation cloud applications. Turbo targets industries including construction, healthcare, manufacturing, retail, and telecommunications. The company announced an $8 million Series A funding round led by Mayfield to support product rollout and growth. Turbo positions itself to increase user engagement with existing systems of record by adding personalized, high-engagement application layers without replacing backend systems.
Team
Marilyn Agbeko
Venture Partner
LinkedIn